Bone Biologics Corp

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

BBLG

organization

SIC: 3842

SEC Insider

$24.4M

151 transactions

Summary

Bone Biologics Corp (BBLG) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $1.9MSales: $370K25 insiders

Date	Insider	Type	Value
2026-01-08	Frelick Jeff(Chief Executive Officer)	A	$0
2026-01-08	Walsh Deina H(Chief Financial Officer)	A	$0
2025-06-04	Angle Siddhesh Rajendra	A	$0
2025-06-04	Gagnon Robert E.	A	$0
2025-06-04	Meikle Phillip Terry II	A	$0
2025-06-04	Stroever Bruce	A	$0
2025-01-15	Walsh Deina H(Chief Financial Officer)	A	$0
2025-01-15	Frelick Jeff(Chief Executive Officer)	A	$0
2024-10-16	Meikle Phillip Terry II	A	$0
2024-10-16	Meikle Phillip Terry II	A	$0
2024-09-17	Angle Siddhesh Rajendra	A	$0
2024-09-17	Gagnon Robert E.	A	$0
2024-09-17	Stroever Bruce	A	$0
2024-01-17	Frelick Jeff(Chief Executive Officer)	A	$0
2024-01-17	Walsh Deina H(Chief Financial Officer)	A	$0
2024-01-08	Gagnon Robert E.	A	$0
2024-01-08	Gagnon Robert E.	A	$0
2023-09-18	Stroever Bruce	A	$0
2023-09-18	Angle Siddhesh Rajendra	A	$0
2023-09-18	Lucera Erick	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Bone Biologics Corp — Contributions, Lobbying & Contracts | Poliscope